James M. Shanahan active positions
| Companies | Position | Start | End |
|---|---|---|---|
SynDevRx, Inc.
 SynDevRx, Inc. Miscellaneous Commercial ServicesCommercial Services SynDevRx, Inc. develops treatments for metabolic-related diseases. Its product includes SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active small molecule fumagillol derivative in vivo. The company was founded by James M. Shanahan and Bradley J. Carver and is headquartered in Cambridge, MA. | Director/Board Member | - | - |
| Founder | - | - | |
| Corporate Officer/Principal | - | - |
Career history of James M. Shanahan
Former positions of James M. Shanahan
| Companies | Position | Start | End |
|---|---|---|---|
Jam Technologies, Inc.
 Jam Technologies, Inc. SemiconductorsElectronic Technology Jam Technologies, Inc. manufactures and supplies semiconductor devices. The company designs audio system interface chips for audio-centric consumer electronics, including flat panel TVs, computers, and portable media players. It offers True Fidelity sub-ranging pulse width modulation digital amplifiers. Jam Technologies was founded by James M. Shanahan & Larry Kirn in 1999 and is headquartered in Austin, TX | Founder | 1998-12-31 | 2009-01-19 |
| Sales & Marketing | 1998-12-31 | 2009-01-19 |
Statistics
International
| United States | 3 |
Operational
| Founder | 2 |
| Sales & Marketing | 1 |
| Director/Board Member | 1 |
Sectoral
| Electronic Technology | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Jam Technologies, Inc.
Jam Technologies, Inc. SemiconductorsElectronic Technology Jam Technologies, Inc. manufactures and supplies semiconductor devices. The company designs audio system interface chips for audio-centric consumer electronics, including flat panel TVs, computers, and portable media players. It offers True Fidelity sub-ranging pulse width modulation digital amplifiers. Jam Technologies was founded by James M. Shanahan & Larry Kirn in 1999 and is headquartered in Austin, TX | Electronic Technology |
SynDevRx, Inc.
SynDevRx, Inc. Miscellaneous Commercial ServicesCommercial Services SynDevRx, Inc. develops treatments for metabolic-related diseases. Its product includes SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active small molecule fumagillol derivative in vivo. The company was founded by James M. Shanahan and Bradley J. Carver and is headquartered in Cambridge, MA. | Commercial Services |
- Stock Market
- Insiders
- James M. Shanahan
- Experience
